Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
Completed · Phase 1
Conditions studied: Contraception
In brief
This is a randomized, multi-center, parallel-group Phase I study to evaluate the pharmacodynamics (PD) of Medroxyprogesterone Acetate (MPA) after a single subcutaneous (SC) injection of 150 mg/mL or 300 mg/2 mL Depo-Provera CI in the abdomen of women of reproductive age with a confirmed ovulatory baseline cycle.
Key facts
- Study ID
- NCT02456584
- Run by
- FHI 360
- People needed
- 42
- Starts
- 2015-09-01
- Expected to finish
- 2018-08-30
- Last updated by the study team
- 2018-10-18
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.
Where it is running
- Oregon Health & Science University — Portland, Oregon, United States
- Asociación Dominicana Pro Bienestar de la Familia, Inc. (PROFAMILIA) — Santo Domingo, Dominican Republic
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.